EVOGENE (EVGN) Stock: Buy, Sell, or Hold?
EVGN - EVOGENE LTD.
$0.43
-0.01 (-2.43%)
▼
5d:
+2.24%
30d:
-21.21%
90d:
-3.03%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 19, 2026
Get Alerted When EVGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EVGN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EVGN is currently trading at $0.42, which is considered oversold relative to its 30-day fair value range of $0.44 to $0.54.
Technical Outlook: Technically, EVGN is in a downtrend. Immediate support is located at $0.35, while resistance sits at $0.52.
Market Sentiment: EVGN scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.15 (+405.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EVGN is in a downtrend. Immediate support is located at $0.35, while resistance sits at $0.52.
Market Sentiment: EVGN scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $2.15 (+405.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.44 -
$0.54
Company Quality Score
57/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: Trading 405.9% below Wall St target ($2.15)
- CAUTION: Bottoming setup, but lagging the sector by 36% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$0.44 -
$0.54
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.35
Resistance Level
$0.52
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.71
Wall Street Target
$2.15
(+405.9%)
Revenue Growth (YoY)
-60.7%
Share & Embed Analysis
Last updated: October 03, 2026 12:25 AM ET
Data refreshes hourly during market hours. Next update: 1:25 AM
Data refreshes hourly during market hours. Next update: 1:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EVGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
